Apremilast, a novel small mol. inhibitor of PDE4. Apremilast has profound anti-inflammatory properties in animal models of inflammatory disease, as well as human chronic inflammatory diseases such as psoriasis and psoriatic arthritis. Apremilast blocks the synthesis of several pro-inflammatory cytokines and chemokines, such as tumor necrosis factor alpha, interleukin 23, CXCL9, and CXCL10 in multiple cell types. As this novel PDE4 inhibitor interferes with several key processes of inflammation, Apremilast may emerge as a promising new drug for the treatment of chronic inflammatory diseases such as those of the skin and the joints.

June 21, 2017

prudect name : Apremilast, a novel small mol. inhibitor of PDE4. Apremilast has profound anti-inflammatory properties in animal models of inflammatory disease, as well as human chronic inflammatory diseases such…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

prudect name : AmlodipineSynonyms: CAS NO: 88150-42-9Molecular Formula: C20H25ClN2O5Molecular Weight: 408.88Purity: 98% minSolubility: In DMSOStorage:

prudect name : Amlodipine Synonyms: CAS NO: 88150-42-9Molecular Formula: C20H25ClN2O5Molecular Weight: 408.88Purity: 98% minSolubility: In DMSOStorage: −20°C 847591-62-2 References PubMed ID๏ผš:http://www.ncbi.nlm.nih.gov/pubmed/18500334

๐Ÿ“Œ
0๐Ÿ’ฌ read more

AMG-073 HCl (Cinacalcet hydrochloride) represents a new class of compounds for the treatment of hyperparathyroidism known as calcimimetics, which reduce parathyroid hormone (PTH) synthesis and secretion by increasing the sensitivity of the parathyroid calcium-sensing receptor (CaR) to extracellular calcium. The current study evaluates the efficacy and safety of AMG 073 when added to conventional treatment of secondary hyperparathyroidism in end-stage renal disease (ESRD).

prudect name : AMG-073 HCl (Cinacalcet hydrochloride) represents a new class of compounds for the treatment of hyperparathyroidism known as calcimimetics, which reduce parathyroid hormone (PTH) synthesis and secretion by…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

AZ628 is a potent tyrosine protein inhibitor for wild-type CRAF and BRAF V600E with IC50 of 29 and 34 nM, respectively. AZ628 inhibits activities of preactivated wild-type B-Raf with an IC50 of 105, respectively. AZ628 also suppreses activities of a number of tyrosine protein kinases such as VEGFR2, DDR2, Lyn and Flt1, as well as FMS. [1] AZ628 also prevents anchorage-dependent and -independent growth, gives rise to cell cycle arrest, and triggers apoptosis in colon and melanoma cell lines harboring B-RafV600E mutation. AZ628 is antiangiogenic based on inhibition of VEGFR2.

prudect name : AZ628 is a potent tyrosine protein inhibitor for wild-type CRAF and BRAF V600E with IC50 of 29 and 34 nM, respectively. AZ628 inhibits activities of preactivated wild-type…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

ARN-509 is an androgen receptor antagonist with potential antineoplastic activity. ARN-509 binds to AR in target tissues thereby preventing androgen-induced receptor activation and facilitating the formation of inactive complexes that cannot be translocated to the nucleus. This prevents binding to and transcription of AR-responsive genes. This ultimately inhibits the expression of genes that regulate prostate cancer cell proliferation and may lead to an inhibition of cell growth in AR-expressing tumor cells

prudect name : ARN-509 is an androgen receptor antagonist with potential antineoplastic activity. ARN-509 binds to AR in target tissues thereby preventing androgen-induced receptor activation and facilitating the formation of…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

AST-1306 is a novel irreversible epidermal growth factor receptor inhibitor for EGFR and ErbB4 with IC50 of 0.5 and 0.8 nM, respectively. AST-1306 selectively inhibits the tyrosine kinase activities of ErbB2 with an IC50 of 3 nM. AST-1306 also potently prevents the EGFR T790M/L858R double mutant with an IC50 value of 12 nM.

prudect name : AST-1306 is a novel irreversible epidermal growth factor receptor inhibitor for EGFR and ErbB4 with IC50 of 0.5 and 0.8 nM, respectively. AST-1306 selectively inhibits the tyrosine…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

Alfacalcidol (1-hydroxycholecalciferol; Alpha D3; 1.alpha.-Hydroxyvitamin D3) is a non-selective VDR activator medication.

prudect name : Alfacalcidol (1-hydroxycholecalciferol; Alpha D3; 1.alpha.-Hydroxyvitamin D3) is a non-selective VDR activator medication.Alfacalcidol Synonyms: CAS NO: 41294-56-8Molecular Formula: C27H44O2Molecular Weight: C27H44O2Purity: 98% minSolubility: In DMSOStorage: −20°C 1108743-60-7 References…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

AG-120 is an orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1), with potential antineoplastic activity.

prudect name : AG-120 is an orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1), with potential antineoplastic activity.AG-120;AG 120 Synonyms: CAS NO: 1448346-63-1Molecular Formula: C28H22ClF3N6O3Molecular Weight: 582.96Purity: 98% minSolubility:…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

AUY-922 is a derivative of 4,5-diarylisoxazole and a third-generation heat shock protein 90 (Hsp90) inhibitor with potential antineoplastic activity. Hsp90 inhibitor AUY922 has been shown to bind with high affinity to and inhibit Hsp90, resulting in the proteasomal degradation of oncogenic client proteins; the inhibition of cell proliferation; and the elevation of heat shock protein 72 (Hsp72) in a wide range of human tumor cell lines. Hsp90, a 90 kDa molecular chaperone, plays a key role in the conformational maturation, stability and function of other substrate or “client” proteins within the cell, many of which are involved in signal transduction, cell cycle regulation and apoptosis, including kinases, transcription factors and hormone receptors. Hsp72 exhibits anti-apoptotic functions; its up-regulation may be used as a surrogate marker for Hsp90 inhibition.

prudect name : AUY-922 is a derivative of 4,5-diarylisoxazole and a third-generation heat shock protein 90 (Hsp90) inhibitor with potential antineoplastic activity. Hsp90 inhibitor AUY922 has been shown to bind…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

prudect name : AtazanavirSynonyms: CAS NO: 198904-31-3Molecular Formula: C38H52N6O7Molecular Weight: 704.87Purity: 98% minSolubility: In DMSOStorage:

prudect name : Atazanavir Synonyms: CAS NO: 198904-31-3Molecular Formula: C38H52N6O7Molecular Weight: 704.87Purity: 98% minSolubility: In DMSOStorage: -20°C 129497-78-5 References PubMed ID๏ผš:http://www.ncbi.nlm.nih.gov/pubmed/18499914

๐Ÿ“Œ
0๐Ÿ’ฌ read more